Rocket Pharmaceuticals, Inc. Interest Payable, Current
Rocket Pharmaceuticals, Inc. (RCKT) had Interest Payable, Current of $0 as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2022-02-28
- 2021-12-31: Interest Payable, Current $0.00.
- 2021-09-30: Interest Payable, Current $0.00.
- 2021-06-30: Interest Payable, Current $123.00K.
- 2021-03-31: Interest Payable, Current $449.00K.
| Period end | Interest Payable, Current | Interest Payable, Current as first filed |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $123.00K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $449.00K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $1.12M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $620.00K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $1.25M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $500.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $1.24M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $493.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.24M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $493.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.24M 10-K · filed 2020-03-06 | |
| 2018-09-30 | $493.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.24M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $493.00K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-08 | $1.25M 10-K · filed 2018-03-07 |
| 2017-09-30 | $484.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $1.23M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $480.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.20M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $451.00K 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $366.00K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $104.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |